No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
VEEV Veeva Systems
- 205.760
- -3.480-1.66%
Close May 22 16:00 ET
- 206.910
- +1.150+0.56%
Pre 08:33 ET
33.25BMarket Cap63.90P/E (TTM)
210.960High205.260Low733.25KVolume208.710Open209.240Pre Close151.65MTurnover0.50%Turnover Ratio63.90P/E (Static)161.61MShares236.90052wk High7.16P/B30.47BFloat Cap162.36052wk Low--Dividend TTM148.10MShs Float343.960Historical High--Div YieldTTM2.72%Amplitude17.110Historical Low206.815Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
New Veeva Pulse Findings Show Connected Engagement Creates an Advantage as HCP Access Drops
Veeva Systems (NYSE: VEEV) today unveiled the latest findings from its Veeva Pulse Field Trends Report. The analysis finds that healthcare...
For the Second Year in a Row, Veeva MedTech Named Best Overall Medtech Software
Veeva Systems (NYSE: VEEV) today announced that Veeva MedTech was named "Best Overall MedTech Software" for the second year in a row in the 8th...
Veeva Systems (VEEV) Stock Drops Despite Market Gains: Important Facts to Note
Cumbre Europea De I+D Y Calidad De Veeva
- Los líderes biofarmacéuticos dan forma al futuro del desarrollo de fármacos en la Cumbre Europea de I+D y Calidad de Veeva Ascendis, Bayer, Boehringer Ingelheim, Jazz Pharmaceuticals, Novo Nordi
Barclays Reaffirms Their Buy Rating on Veeva Systems (VEEV)
Masimo's (MASI) New Offering to Serve Personalized Audio Market
Comments
The company's Total Shareholder Return (TSR) for the year was broadly in line with the market average, at 35%. The year's return is actually better than the average return over five years, which was 13%. This suggests that the business could be worth watching in the long term.
Veeva Systems' (NYSE:VEEV) Investors Will Be Pleased With Their Favorable 86% Return Over the Last Five Years 1
Veeva Systems' Q4 results showed strong revenue and EPS, but Q1 2025 revenue guidance disappointed. Its robust free cash flow, driven by an asset-lite business model, scale advantages, and strong competitive positioning, provides flexibility for capital return or reinvestment.
1
VEEV - Long term looks good!
Wider View
- Post COVID run built towards a distribution range between 260 and 330
- With the rate hikes, VEEV went on a sell down but has since been on an accumulation phase from 2022 until now
- And we are now at another possible attempt to break out the accumulation range
- Upside could be movement up to previous range again or up to 290 (middle of range)
Bullish View
- Price action moves in distribution and accumulation so it is eno...
Wider View
- Post COVID run built towards a distribution range between 260 and 330
- With the rate hikes, VEEV went on a sell down but has since been on an accumulation phase from 2022 until now
- And we are now at another possible attempt to break out the accumulation range
- Upside could be movement up to previous range again or up to 290 (middle of range)
Bullish View
- Price action moves in distribution and accumulation so it is eno...
6
3
Veeva Systems' high P/E ratio is alarming due to its below-market predicted growth, indicating a potential drop in share price. Without substantial improvements, current prices may not hold.
Price action
- Entire 2022 and 2023 had been moving in range (between 160 and 225)
- Mid range is 193 (and guess where it is now ending 2023)
- Significant gap down on 9 Nov 2023 but has since fully filled the gap as of end 2023
- MA5 has since crossed above MA20 and MA20 is also soon to cross MA50
- On weekly charts, price action has moved above MA50 too (187)
My plays with optimism
- Any pullbacks I will grab at about 186 ...
- Entire 2022 and 2023 had been moving in range (between 160 and 225)
- Mid range is 193 (and guess where it is now ending 2023)
- Significant gap down on 9 Nov 2023 but has since fully filled the gap as of end 2023
- MA5 has since crossed above MA20 and MA20 is also soon to cross MA50
- On weekly charts, price action has moved above MA50 too (187)
My plays with optimism
- Any pullbacks I will grab at about 186 ...
5
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
